• 28275 Citations
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
Comment/debate

Brain metastasis in breast cancer: Last barrier to the cure?

Dawood, S. & Cristofanilli, M., Jan 1 2012, In : Oncology (Williston Park, N.Y.). 26, 7

Research output: Contribution to journalComment/debate

1 Scopus citations

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

Barsan, V., Cristofanilli, M. & Mani, S. A., Jan 1 2013, In : Breast Diseases. 24, 3, p. 225-226 2 p.

Research output: Contribution to journalComment/debate

Circulating tumor cells: Toward sophisticated approaches in managing metastatic breast cancer

Andreopoulou, E. & Cristofanilli, M., Jun 1 2008, In : Oncology. 22, 7

Research output: Contribution to journalComment/debate

Circulating tumor cells in aggressive breast cancer

Cristofanilli, M. & Penne, J., Sep 1 2004, In : Cancer Biology and Therapy. 3, 9, p. 795-796 2 p.

Research output: Contribution to journalComment/debate

Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?

Cristofanilli, M. & Mendelsohn, J., Nov 14 2006, In : Proceedings of the National Academy of Sciences of the United States of America. 103, 46, p. 17073-17074 2 p.

Research output: Contribution to journalComment/debate

53 Scopus citations

Circulating tumor cells revisited

Cristofanilli, M. & Braun, S., Mar 17 2010, In : JAMA - Journal of the American Medical Association. 303, 11, p. 1092-1093 2 p.

Research output: Contribution to journalComment/debate

35 Scopus citations

Circulating tumour cells: Telling the truth about metastasis

Cristofanilli, M., Jan 1 2014, In : The Lancet Oncology. 15, 4, p. 365-366 2 p.

Research output: Contribution to journalComment/debate

16 Scopus citations

Clinical utility of measuring circulating tumor cells in metastatic breast cancer

Guarneri, V. & Cristofanilli, M., Jan 1 2006, In : Clinical breast cancer. 7, 1, p. 85-86 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

Rolfo, C., Cardona, A. F., Cristofanilli, M., Paz-Ares, L., Diaz Mochon, J. J., Duran, I., Raez, L. E., Russo, A., Lorente, J. A., Malapelle, U., Gil-Bazo, I., Jantus-Lewintre, E., Pauwels, P., Mok, T. & Serrano, M. J., Oct 2020, In : Critical Reviews in Oncology/Hematology. 154, 103058.

Research output: Contribution to journalComment/debate

Corrigendum to “Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor‒positive (HR+)/human epidermal growth factor receptor 2‒negative (HER2–) advanced breast cancer (ABC): Subgroup analysis of 2 randomized phase 3 studies” (The Breast (2018) 41(S1) (S11–S12), (S0960977618301760), (10.1016/j.breast.2018.08.033))

Cristofanilli, M., Harbeck, N., Rugo, H. S., Castrellon, A., Joy, A. A., Verma, S., Im, S. A., Iyer, S., Puyana Theall, K., Gauthier, E., Huang, X., Bartlett, C. H., Loibl, S. & Finn, R. S., Feb 2020, In : Breast. 49, 1 p.

Research output: Contribution to journalComment/debate

Open Access

Erratum: A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer (J Surg Res (2009) 155 (231))

Huang, E. H., Singh, B., Cristofanilli, M., Gelovani, J., Wei, C., Vincent, L., Cook, K. R. & Lucci, A., Jan 1 2010, In : Journal of Surgical Research. 162, 2, 1 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Herceptin plus chemotherapy combination in preoperative regimen may offer clinical benefit in early stage breast cancer

Ibrahim, N., Francis, D., Booser, D., Thomas, E., Theriault, R., Pusztai, L., Green, M., Arun, B., Giordano, S., Cristofanilli, M., Frye, D., Smith, T., Hunt, K., Singletary, E., Sahin, A., Ewer, M., Buchholz, T., Berry, D. & Hortobagyi, G., May 2005, In : Cancer Biology and Therapy. 4, 5

Research output: Contribution to journalComment/debate

Inflammatory breast cancer: A new approach

Cristofanilli, M., May 1 2016, In : The Lancet Oncology. 17, 5, p. 544-546 3 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

Metastatic breast cancer: focus on endocrine sensitivity

Cristofanilli, M., Dec 17 2016, In : The Lancet. 388, 10063, p. 2961-2962 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer

Cristofanilli, M., Jan 1 2005, In : Breast Diseases. 15, 4, 1 p.

Research output: Contribution to journalComment/debate

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy

Ali, S. M., Alpaugh, R. K., Downing, S. R., Stephens, P. J., Yu, J. Q., Wu, H., Buell, J. K., Miller, V. A., Lipson, D., Palmer, G. A., Ross, J. S. & Cristofanilli, M., Sep 1 2014, In : Journal of Clinical Oncology. 32, 25, p. e88-e91

Research output: Contribution to journalComment/debate

32 Scopus citations

Time for a shift in molecular down staging in luminal breast cancer

Cristofanilli, M., Jan 2020, In : The Lancet Oncology. 21, 1, p. 2-3 2 p.

Research output: Contribution to journalComment/debate

Two prognostic groups of inflammatory breast cancer have distinct genotypes

Lerebours, F., Bertheau, P., Bieche, I. & Cristofanilli, M., Jul 1 2004, In : Breast Diseases. 15, 2, 1 p.

Research output: Contribution to journalComment/debate